Journal retracts Covaxin study after manufacturer sues for defamation | The BMJ

Retrieved on: 2024-09-26 15:37:49

Tags for this article:

Click the tags to see associated articles and topics

Journal retracts Covaxin study after manufacturer sues for defamation | The BMJ. View article details on hiswai:

Summary

The article discusses the retraction of a post-marketing safety study on Covaxin, an Indian Covid-19 vaccine, by the journal *Drug Safety*. The retraction was due to concerns about data interpretation, leading to debates on drug safety.

Article found on: www.bmj.com

View Original Article